Iván Bontempi

Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease

Iván Bontempi, Miguel Hernán Vicco, Gabriel Cabrera et al. · Vaccine · 2015 · 45 citations

Vaccinology, Vaccination, Vaccine Development +8

Trans-sialidase-based vaccine candidate protects against <i>Trypanosoma cruzi</i> infection, not only inducing an effector immune response but also affecting cells with regulatory/suppressor phenotype

Estefanía Prochetto, Carolina Roldán, Iván Bontempi et al. · Oncotarget · 2017 · 33 citations · Full text

Development and assessment of a new cage-like particle adjuvant

Daiana Bertona, Nazarena Pujato, Iván Bontempi et al. · Journal of Pharmacy and Pharmacology · 2017 · 29 citations · Full text

Genotyping of Trypanosoma cruzi Sublineage in Human Samples from a North-East Argentina Area by Hybridization with DNA Probes and Specific Polymerase Chain Reaction (PCR)

Cristina Diez, Virginia Lorenz, S. Ortíz et al. · American Journal of Tropical Medicine and Hygiene · 2010 · 27 citations · Full text

Genetic Engineering of Lactococcus lactis Co-producing Antigen and the Mucosal Adjuvant 3′ 5′- cyclic di Adenosine Monophosphate (c-di-AMP) as a Design Strategy to Develop a Mucosal Vaccine Prototype

Ingrid M. Quintana, Martín Espariz, Silvina R. Villar et al. · Frontiers in Microbiology · 2018 · 27 citations · Full text